FEMY
Femasys IncKey Statistics
About Femasys Inc
Femasys Inc. is a pioneering medical technology company dedicated to revolutionizing women's healthcare through its advanced proprietary solutions for diagnosing and treating gynecological conditions. The company is noted for its innovative flagship products that provide non-surgical alternatives for prevalent issues such as uterine fibroids and contraception, firmly establishing itself as a leader in the dynamic women's health landscape. As the demand for minimally invasive treatments escalates, Femasys is well-positioned to leverage this trend, delivering enhanced patient outcomes and improving healthcare efficiency. With a strong commitment to addressing substantial unmet needs in women’s health, Femasys seeks to transform the standards of care within this essential sector.
Fundamentals
| Revenue (TTM) | $2.29M |
| Gross Profit (TTM) | $1.42M |
| EBITDA | $-17.25M |
| Operating Margin | -568.00% |
| Return on Equity | -455.80% |
| Return on Assets | -66.30% |
| Revenue/Share (TTM) | $0.06 |
| Book Value | $0.10 |
| Price-to-Book | 4.10 |
| Price-to-Sales (TTM) | 10.50 |
| EV/Revenue | 8.5 |
| EV/EBITDA | 0.24 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 39.90% |
| Shares Outstanding | $60.39M |
| Float | $49.93M |
| % Insiders | 9.28% |
| % Institutions | 10.28% |
Historical Volatility
Volatility is currently contracting